Senti Biosciences Holdings (SNTI) Cash & Current Investments (2021 - 2025)

Senti Biosciences Holdings' Cash & Current Investments history runs 5 years deep, the most recent figure standing at $16.4 million for Q4 2025.

• In Q4 2025, Cash & Current Investments fell 66.05% year-over-year to $16.4 million; the TTM figure through Dec 2025 stood at $16.4 million (down 66.05% YoY), while the FY2025 annual figure was $16.4 million, down 66.05% from the prior year.
• Cash & Current Investments for Q4 2025 stood at $16.4 million, up from $12.2 million in the prior quarter.
• The five-year high for Cash & Current Investments was $139.8 million in Q2 2022, with the low at $10.5 million in Q3 2024.
• The 5-year median for Cash & Current Investments is $39.4 million (2023), against an average of $52.5 million.
• The sharpest annual moves came in 2023 and 2024: Cash & Current Investments soared 99.54% in 2023, then plunged 73.37% in 2024.
• Senti Biosciences Holdings' Cash & Current Investments stood at $56.0 million in 2021, then surged by 75.9% to $98.6 million in 2022, then plunged by 63.55% to $35.9 million in 2023, then surged by 34.44% to $48.3 million in 2024, then tumbled by 66.05% to $16.4 million in 2025.
• Business Quant data shows SNTI's Cash & Current Investments at $16.4 million in Q4 2025, $12.2 million in Q3 2025, and $21.6 million in Q2 2025.